Okomera joined the EIC Advanced Innovation Challenges, one of Europe’s most competitive innovation funding programs, after more than 700 applications.
Published
Signal category
Capital & Finance
Quote
“Okomera is proud to join the #EICAdvancedInnovationChallenges, one of Europe’s most competitive innovation funding programs.”
— Okomera team
Company
Okomera
We turn tumor response into treatment decisions.
- Industry
- Biotechnology Research
- Location
- Paris, FR
- Company size
- 24 employees
Okomera has developed a proprietary technology platform that transforms patient biopsies into multiple miniaturized tumor avatars, enabling rapid assessment of treatment response in real-world conditions. Designed as a decentralized lab for clinicians and biopharma companies, the platform seamlessly converges cutting-edge hardware, software, and biological technologies into a single integrated system, making functional precision medicine accessible at scale. We are building a future where every cancer patient receives the right treatment from the start.
Founded 2020